Trial Details
COMPLETEDBasic Information
| Clinical ID | c3419 |
|---|---|
| Identifier | NCT02086968 |
| Trial Title | Treatment Response of Injectafer vs Oral Iron to Baseline Hepcidin Levels in Patients With Iron Deficiency Anemia (IDA) Secondary to Inflammatory Bowel Disease (IBD) or Gastric Bypass |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Iron Deficiency Anemia Secondary to IBD or Gastric Bypass |
| Interventions | DRUG: Injectafer|DRUG: Ferrous Sulfate tablets |
Participant Information
| Sponsor | American Regent, Inc. |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2014-01-01 |
|---|---|
| Primary Completion Date | 2016-07-16 |
| Completion Date | 2017-10 |